NUAK2 is a YAP/TAZ target gene that promotes tumor progression in liver and bladder cancer [91,92], and CTGF, a well-established YAP/TAZ target gene, has clear roles in cancer [93]. The gene discussed is NUAK2; the disease is urinary bladder carcinoma.